Pages that link to "Q43119401"
Jump to navigation
Jump to search
The following pages link to Cancer: antitumor effects of octreotide LAR, a somatostatin analog (Q43119401):
Displaying 11 items.
- Screening of well-established drugs targeting cancer metabolism: reproducibility of the efficacy of a highly effective drug combination in mice (Q33927565) (← links)
- Phosphorylation of sst2 receptors in neuroendocrine tumors after octreotide treatment of patients (Q35951881) (← links)
- Somatostatin-based radiotherapy with [90Y-DOTA]-TOC in neuroendocrine tumors: long-term outcome of a phase I dose escalation study (Q36578624) (← links)
- Advances in the therapy of gastroenteropancreatic-neuroendocrine tumours (GEP-NETs). (Q37771118) (← links)
- Signaling Pathways as Specific Pharmacologic Targets for Neuroendocrine Tumor Therapy: RET, PI3K, MEK, Growth Factors, and Notch (Q37985518) (← links)
- The New Concept of Therapeutic Strategy for Neuroendocrine Tumors: Important Information from a Case Report of Gastrinoma (Q42914547) (← links)
- Tumor regression with a combination of drugs interfering with the tumor metabolism: efficacy of hydroxycitrate, lipoic acid and capsaicin (Q43561120) (← links)
- Somatostatin-based radiopeptide therapy with [177Lu-DOTA]-TOC versus [90Y-DOTA]-TOC in neuroendocrine tumours (Q44712034) (← links)
- Metastatic Recurrence of Typical Pulmonary Carcinoid Accompanied by Carcinoid Syndrome, Successfully Treated with Octreotide LAR. (Q49404597) (← links)
- Immunohistochemical evaluation of somatostatin receptor subtypes in surgical pathology specimens of neuroendocrine tumors (Q84974647) (← links)
- A case of pancreatic neuroendocrine tumors (Q92433276) (← links)